Invesco Biotechnology & Genome ETF
PBE
PBE
86 hedge funds and large institutions have $64.6M invested in Invesco Biotechnology & Genome ETF in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
86
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.48M | |
| 2 | +$1.42M | |
| 3 | +$790K | |
| 4 |
DWM
Dakota Wealth Management
Palm Beach Gardens,
Florida
|
+$759K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$747K |
Top Sellers
| 1 | -$3.86M | |
| 2 | -$626K | |
| 3 | -$546K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$306K |
| 5 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$222K |